Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

Federal funding opportunity RFA-AI-27-005 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes November 10, 2026

Program funding history

Synopsis

Who can apply

• Special district governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Native American tribal organizations (other than Federally recognized tribal governments)
• For profit organizations other than small businesses
• Small businesses
• Independent school districts
• Private institutions of higher education
• Public and State controlled institutions of higher education
• County governments
• Native American tribal governments (Federally recognized)
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Public housing authorities/Indian housing authorities
• State governments
• City or township governments
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards. Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

How to apply

Similar grants

• Collaborative Network for Clinical Research on Immune Tolerance
  RFA-AI-28-005 · National Institutes of Health
• Childhood Asthma in Urban Settings Clinical Research Network
  RFA-AI-28-007 · National Institutes of Health
• Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
  RFA-AI-27-002 · National Institutes of Health · closes November 10, 2026
• Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
  PA-24-182 · National Institutes of Health · closes May 8, 2027
• Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)
  PAR-27-076 · National Institutes of Health · closes July 7, 2028
• HIV/AIDS Clinical Trials Network Leadership and Operations Centers
  RFA-AI-28-001 · National Institutes of Health